Where diverse expertise creates fresh perspectives

We are geneticists, immunologists, statisticians, systems biologists, data scientists, programmers, and software engineers passionate about advancing therapeutic development through biomarkers.

Everyday QuartzBio helps our clients generate value from large-scale heterogeneous biomedical data—managing, analyzing, exploring, interpreting, and reporting—to create informed, sound, and actionable insights.

Where diverse expertise creates fresh perspectives

We are geneticists, immunologists, statisticians, systems biologists, data scientists, programmers, and software engineers passionate about advancing therapeutic development through biomarkers.

Everyday QuartzBio helps our clients generate value from large-scale heterogeneous biomedical data—managing, analyzing, exploring, interpreting, and reporting—to create informed, sound, and actionable insights.

Our global solution

Our global solution

About Precision for Medicine

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments more precisely and effectively. Precision applies novel biomarker approaches to clinical research, leveraging the latest advancements in science and technology. The Precision for Medicine QuartzBio multiomic data integration and informatics platform enables life sciences companies to discover hidden subgroups of patients who will most benefit from a given therapy, delivering the means for truly personalized medicine. Precision for Medicine is part of Precision Medicine Group, with over 2,000 employees in 35 locations in the US, Canada, and Europe.

News & Insights

More information and news about QuartzBio and Precision for Medicine

Poster: Reverse Causal Inferencing on Lung Adenocarcinoma Patients Reveals a Stem Cell–Like Molecular Subtype Associated With Pack-Year History

Press Release: Boston Office Launches, Computational Biology Expanded

QuartzBio in Clinical Omics

Press Release: Acquisition of SimplicityBio Enhances QuartzBio

Precision Translational Solutions

QuartzBio in Journal for Clinical Studies

Featured Content

White Paper: From Data Chaos to Order & Insight: Creating a Connected Data Ecosystem to Drive Drug Development

News & Insights

More information and news about QuartzBio and Precision for Medicine

Poster: Reverse Causal Inferencing on Lung Adenocarcinoma Patients Reveals a Stem Cell–Like Molecular Subtype Associated With Pack-Year History

Press Release: Boston Office Launches, Computational Biology Expanded

QuartzBio in Clinical Omics

Press Release: Acquisition of SimplicityBio Enhances QuartzBio

Precision Translational Solutions

QuartzBio in Journal for Clinical Studies

Featured Content

White Paper: From Data Chaos to Order & Insight: Creating a Connected Data Ecosystem to Drive Drug Development

Partner with us to harness
the power of your data